Farmaceutica REMEDIA S.A (RMAH) Fair Value & Analysis
Healthcare · RO · Market cap 74.0M RON
Fair value as of: Jul 19, 2026
From 22 valuation models · updated today
Fair value updated Jul 19, 2026, revised from 2.55 RON to 1.72 RON (−32.5%) since Jun 24, 2026. Share price −11.8% over the past month.
Price vs Fair Value (12 months)
12‑month range 0.6568 RON – 0.9380 RON · fair‑value band 1.29 RON – 2.14 RON · the 0.7900 RON price screens below the 1.72 RON fair value. As of Jul 19, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Farmaceutica REMEDIA S.A (RMAH) currently trades at 0.7900 RON, while our model-based Fair Value estimate is 1.72 RON, implying the stock looks roughly 117.7% undervalued today. We read business quality at 57/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.
Over the trailing twelve months, Farmaceutica REMEDIA S.A generated revenue of 740M RON at a net margin of 0.8%. Revenue declined 10.9% year over year. It earns a return on equity of 7.5%. The stock trades on a trailing P/E of 9.9. Fundamentals as of Jul 19, 2026
Our scenario range runs from 1.29 RON (bear case) to 2.14 RON (bull case); at 0.7900 RON, the current price sits below that range. The share trades about 17% below its 52-week high and 20% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at 24% fair-value upside, at 118%, RMAH screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 19, 2026. TTM = trailing twelve months.
About the company
Farmaceutica REMEDIA S.A. operates a chain of pharmacies in Romania. It is also involved in the wholesale distribution of medicines to pharmacies, and public and private hospitals and clinics. In addition, the company provides packaging materials; and logistics and warehousing, promotion and marketing of drugs, and pharmaceutical products registration services. The company was incorporated in 1991 and is headquartered in Deva, Romania.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Farmaceutica REMEDIA S.A reported revenue of 760M RON in FY2025 versus 477M RON in FY2021, a compound +12.3%/yr. Reported net income was 8.0M RON in FY2025, compounding +2.7%/yr from FY2021.
Is RMAH fairly valued? → Check now
Similar stocks
10 more Medical Distribution stocks, each showing price versus our Fair Value estimate (as of Jul 19, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| McKesson Corporation M1CK34 | R$999.49 | R$1,236 | +24% |
| Cencora, Inc COR | $270.32 | $168.24 | -38% |
| Cardinal Health, Inc CAH | $201.74 | $92.07 | -54% |
| Sigma Healthcare Limited SIGGF | $2.35 | $0.7800 | -67% |
| Henry Schein, Inc HSIC | $78.85 | $62.37 | -21% |
| Shanghai Pharmaceuticals Holding 601607 | ¥15.96 | ¥45.15 | +183% |
| Sinopharm Group 1099 | HK$16.74 | HK$61.33 | +266% |
| Galenica AG GALNF | $115.00 | $98.28 | -15% |
| Guangzhou Baiyunshan Pharmaceutical Holdings 600332 | ¥20.81 | ¥30.70 | +48% |
| Medipal Holdings MEPDF | $18.35 | $29.88 | +63% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Farmaceutica REMEDIA S.A (RMAH) undervalued?
What is the fair value of RMAH?
What is the quality score of RMAH?
What is the revenue of Farmaceutica REMEDIA S.A (RMAH)?
What is the net profit margin of RMAH?
Does Farmaceutica REMEDIA S.A pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Tell me when Farmaceutica REMEDIA S.A reaches its Fair Value
Just your email, and we'll notify you when the price and Fair Value of Farmaceutica REMEDIA S.A materially change. Free bonus: the monthly Top-25 report of the most undervalued quality stocks.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.